Search (News)

BIIB Stock Ends 3% Higher - Why This Strategist Picks Biogen Over Other Biotech Peers

english top health

(MENAFN - AsiaNet News) Woods noted that Biogen has multiple focuses across autoimmune kidney diseases and Alzheimer's, unlike many names in the sector, which rely on a specific drug ...
2026-07-02 20:45:19